Skip to main content

Table 4 Univariate Cox and multinomial logistic regression for nutritional status of patients with pediatric inflammatory bowel disease

From: Analysis and prediction of nutritional outcome of patients with pediatric inflammatory bowel disease from Bahrain

Variable

Cox regression

Multinomial logistic regression

Abnormal vs. normal

Thinness vs. normal

Overweight vs. normal

 

HR (95% CI)

P value

OR (95% CI)

P value

OR (95% CI)

P value

 

Demographic data

       

Male sex

1.07 (0.61–1.66)

0.979

0.85 (0.27–2.68)

0.784

1.17 (0.53–2.58)

0.690

 

Bahraini nationality

0.3 (0.17–0.54)

< 0.001

58930879.04

1.000

3.98 (1.08–14.65)

0.038

 

Normal delivery

0.46 (0.1–2.12)

0.316

22198171.35

1.000

0.16 (0.03–0.93)

0.042

 

Crohn’s disease IBD type

1.95 (1.18–3.23)

0.009

1.21 (0.37–3.93)

0.752

0.47 (0.22–0.99)

0.048

 

Pre-diagnosis disease duration

1.01 (0.96–1.06)

0.725

1.05 (0.98–1.11)

0.160

1.03 (0.97–1.09)

0.332

 

Post-diagnosis disease duration

0.0 (0.0–0.0)

< 0.001

1.02 (0.93–1.12)

0.676

1.11 (1.04–1.17)

< 0.001

 

Age at presentation

0.99 (0.93–1.05)

0.694

0.86 (0.74–1.01)

0.063

1.02 (0.91–1.13)

0.769

 

Age at follow up

0.81 (0.77–0.86)

< 0.001

0.97 (0.89–1.06)

0.547

1.08 (1.03–1.13)

0.002

 

Very early onset IBD

0.42 (0.17–1.05)

0.064

6.4 (1.57–26.15)

0.010

1.92 (0.55–6.71)

0.307

 

Clinical manifestation

       

Diarrhea

0.52 (0.31–0.89)

0.016

2.0 (0.51–7.83)

0.320

1.67 (0.68–4.12)

0.268

 

Recurrent abdominal pain

1.09 (0.65–1.82)

0.746

0.57 (0.18–1.78)

0.334

0.8 (0.35–1.82)

0.595

 

Weight loss

1.7 (1.03–2.8)

0.037

3.33 (0.86–12.92)

0.082

0.37 (0.16–0.85)

0.020

 

Pallor

1.61 (0.97–2.67)

0.067

0.96 (0.31–3.02)

0.948

1.01 (0.45–2.25)

0.991

 

Anorexia

1.3 (0.8–2.13)

0.296

0.96 (0.31–3.02)

0.948

0.72 (0.32–1.65)

0.441

 

Vomiting

1.03 (0.61–1.74)

0.903

1.43 (0.45–4.54)

0.545

0.64 (0.26–1.59)

0.340

 

Arthralgia

1.12 (0.64–1.94)

0.695

0.72 (0.18–2.87)

0.642

0.99 (0.4–2.46)

0.989

 

Perianal disease

1.92 (1.06–3.45)

0.031

1.14 (0.32–4.07)

0.844

1.08 (0.43–2.69)

0.873

 

Fever

1.5 (0.81–2.78)

0.198

0.63 (0.13–3.13)

0.570

0.89 (0.32.-2.47)

0.826

 

Constipation

1.72 (0.89–3.32)

0.107

0.77 (0.15–3.9)

0.751

0.74 (0.24–2.3)

0.597

 

Skin rash

2.43 (1.26–4.69)

0.008

0.0 (0.0–0.0)

1.000

0.27 (0.06–1.29)

0.101

 

Jaundice

0.84 (0.31–2.32)

0.739

2.39 (0.39–14.42)

0.344

0.0 (0.0–0.0)

1.000

 

Hematemesis

1.5 (0.47–4.82)

0.492

1.5 (0.15–15.51)

0.734

0.55 (0.06–5.51)

0.613

 

Extraintestinal manifestations

1.44 (0.88–2.35)

0.147

0.32 (0.08–1.24)

0.098

0.8 (0.36–1.79)

0.583

 

Disease activity at presentation

       

Moderate

0.8 (0.43–1.48)

0.474

1.93 (0.44–8.49)

0.386

1.65 (0.58–4.69)

0.346

 

Severe

0.81 (0.44–1.48)

0.490

1.27 (0.27–5.97)

0.765

1.43 (0.5–4.05)

0.507

 

Growth parameter

       

Birth weight

1.57 (0.67–3.71)

0.300

0.49 (0.13–1.85)

0.289

1.03 (0.3–3.52)

0.962

 

Weight at presentation

0.99 (0.97-1.0)

0.129

0.91 (0.84–0.98)

0.015

1.06 (1.02–1.1)

0.002

 

Height at presentation

0.99 (0.98–0.99)

0.041

0.97 (0.94-1.0)

0.054

1.02 (0.99–1.05)

0.070

 

BMI at presentation

0.91 (0.86–0.98)

0.009

1.16 (1.04–1.29)

0.006

1.16 (1.04–1.28)

0.005

 

Laboratory test

       

Hematocrit %

0.99 (0.97–1.02)

0.684

0.94 (0.89–0.99)

0.034

1.0 (0.96–1.05)

0.895

 

ESR

1.0 (0.99–1.02)

0.569

1.01 (0.98–1.04)

0.554

1.0 (0.98–1.02)

0.963

 

CRP

1.0 (0.99–1.01)

0.571

1.01 (0.99–1.02)

0.128

0.99 (0.98–1.01)

0.367

 

Medical therapy

       

Prednisolone

1.94 (1.02–3.7)

0.043

3.29 (0.39–27.55)

0.271

0.57 (0.23–1.43)

0.230

 

Azathioprine

0.94 (0.55–1.61)

0.823

115975454.6

1.000

0.89 (0.39–2.07)

0.799

 

Mesalazine

0.95 (0.58–1.57)

0.848

0.8 (0.26–2.49)

0.704

1.51 (0.66–3.46)

0.326

 

Biological therapy

0.66 (0.4–1.1)

0.109

2.85 (0.87–9.31)

0.084

1.23 (0.56–2.72)

0.610

 

Exclusive enteral nutrition

1.48 (0.64–3.43)

0.360

1.62 (0.29–8.91)

0.582

0.0 (0.0–0.0)

1.000

 

Omeprazole

1.14 (0.65-2.0)

0.640

2.4 (0.49–11.77)

0.280

0.71 (0.3–1.67)

0.436

 

Folic acid

1.44 (0.83–2.51)

0.200

2.6 (0.53–12.7)

0.238

0.77 (0.33–1.8)

0.548

 

Iron supplementation

1.36 (0.82–2.26)

0.237

1.5 (0.46–4.9)

0.502

1.17 (0.53–2.61)

0.698

 

Vitamin D supplementation

1.29 (0.78–2.13)

0.323

1.88 (0.6–5.9)

0.282

0.98 (0.44–2.16)

0.957

 

Calcium supplementation

0.68 (0.39–1.18)

0.171

3.09 (0.97–9.83)

0.056

1.92 (0.83–4.41)

0.126

 

Multivitamins

1.17 (0.68–2.02)

0.576

3.47 (1.08–11.13)

0.036

0.65 (0.26–1.63)

0.358

 

Ursodeoxycholic acid

0.98 (0.31–3.16)

0.978

1.43 (0.14–14.78)

0.765

0.5 (0.05–4.98)

0.554

 

Fat soluble vitamins

0.77 (0.19–3.18)

0.722

2.18 (0.18–25.75)

0.537

0.76 (0.07–8.7)

0.827

 

Other medications

0.35 (0.11–1.12)

0.076

5.0 (0.9-27.82)

0.066

2.78 (0.63–12.32)

0.179

 
  1. Boldface indicates a statistically significant difference with P < 0.05. HR: Hazard ratio, CI: confidence interval; OR: odd ratio; IBD: inflammatory bowel disease; BMI: body mass index; ESR: erythrocyte sedimentation rate; CRP: C-reactive protein.